Belzutifan Improves Progression-Free Survival for Renal Cell Carcinoma Over Everolimus
The Phase 3 LITESPARK-005 trial sought to understand whether Welireg (belzutifan) was effective in treating advanced renal cell carcinoma (RCC) when compared to other treatments, such as everolimus. According to…